The cysteinyl leukotrienes (cys-LTs) mediate both acute and chronic inflammatory responses in mice, as demonstrated by the attenuation of the IgE/antigen-mediated increase in microvascular permeability and of bleomycin-induced pulmonary fibrosis, respectively, in a strain with targeted disruption of leukotriene C 4 synthase to prevent cys-LT synthesis. Our earlier finding that the acute, but not the chronic, injury was attenuated in a strain with targeted disruption of the cysteinyl leukotriene 1 (CysLT 1 ) receptor suggested that the chronic injury might be mediated through the CysLT 2 receptor. Thus, we generated CysLT 2 receptor-deficient mice by targeted gene disruption. These mice developed normally and were fertile. The increased vascular permeability associated with IgE-dependent passive cutaneous anaphylaxis was significantly reduced in CysLT 2 receptor-null mice as compared with wild-type mice, whereas plasma protein extravasation in response to zymosan A-induced peritoneal inflammation was not altered. Alveolar septal thickening after intratracheal injection of bleomycin, characterized by interstitial infiltration with macrophages and fibroblasts and the accumulation of collagen fibers, was significantly reduced in CysLT 2 receptor-null mice as compared with the wild-type mice. The amounts of cys-LTs in bronchoalveolar lavage fluid after bleomycin injection were similar in the CysLT 2 receptor-null mice and the wildtype mice. Thus, in response to a particular pathobiologic event the CysLT 2 receptor can mediate an increase in vascular permeability in some tissues or promote chronic pulmonary inflammation with fibrosis.
The cysteinyl leukotrienes (cys-LTs), 1 leukotriene (LT) C 4 , LTD 4 , and LTE 4 , are lipid mediators (1, 2) that have been implicated in the pathobiology of allergic and asthmatic inflammatory responses on the basis of the efficacy of specific intervention with a biosynthetic inhibitor (3) or antagonists to a receptor subsequently shown to be the cysteinyl leukotriene 1 (CysLT 1 ) receptor (4) . Two types of human receptors for cys-LTs, designated CysLT 1 receptor and CysLT 2 receptor, belonging to the seventransmembrane, G protein-coupled receptor family, were cloned and shown to be 38% homologous in their amino acid sequences (5) (6) (7) (8) (9) . The rank order of affinities of the cys-LTs for the CysLT 1 and CysLT 2 receptors is LTD 4 Ͼ LTC 4 Ͼ LTE 4 Ͼ Ͼ LTB 4 and LTC 4 ϭ LTD 4 Ͼ Ͼ LTE 4 Ͼ Ͼ LTB 4 , respectively. The CysLT 1 receptor is expressed on airway smooth muscle, monocytes/ macrophages, eosinophils (5, 10, 11) , a subset of neutrophils (11) , mast cells (12, 13) , and endothelial cells (14) . The CysLT 2 receptor is expressed on monocyte/macrophages, airway smooth muscle, cardiac Purkinje cells, adrenal medulla cells, peripheral blood leukocytes, brain cells (7), eosinophils (11, 15) , mast cells (16) , and endothelial cells (17, 18) . We and others have reported that the mouse CysLT 1 receptor can function as a receptor for LTD 4 in transfected cells with a ligand preference similar to that of the human CysLT 1 receptor (19 -22) . The mouse CysLT 2 receptor exhibits a ligand profile of LTC 4 Ն LTD 4 Ͼ Ͼ LTE 4 (22, 23) . In contrast to the extensive studies on the functions of the CysLT 1 receptor (24, 25) , the functional characterization of the CysLT 2 receptor has been limited because of a lack of specific competitive antagonists. In particular, any in vivo role for the CysLT 2 receptor remains unknown.
LTC 4 synthase is the pivotal enzyme for the generation of LTC 4 , the parent compound of the cys-LTs (26 -28) . LTC 4 synthase conjugates reduced glutathione to an epoxide intermediate, LTA 4 , generated from arachidonic acid by 5-lipoxygenase in the presence of the 5-lipoxygenase-activating protein (29) . After carrier-mediated export (30) , glutamic acid and glycine are sequentially cleaved from the glutathione moiety of LTC 4 by ␥-glutamyl transpeptidase (31) or ␥-glutamyl leukotrienase (32) and dipeptidase (33) to form LTD 4 and LTE 4 , respectively. We have shown that the increased vascular permeability in zymosan A-induced, monocyte/macrophage-mediated peritoneal inflammation and in IgE-dependent, mast cell-mediated passive cutaneous anaphylaxis (PCA) is reduced by ϳ50% in LTC 4 synthase-null mice as compared with their wild-type littermates (34) . We then demonstrated by targeted disruption of the CysLT 1 receptor in mice that this alteration of vascular permeability is dominantly mediated through the CysLT 1 receptor (35) . Recently, we found that bleomycin-induced chronic pulmonary inflammation and fibrosis are diminished in LTC 4 synthase-null mice, thereby implicating the cys-LTs in this pathobiology (36) . However, CysLT 1 receptor-null mice were not protected, and this finding suggested a proinflammatory role for the CysLT 2 receptor in the chronic response. To define the role of the CysLT 2 receptor in vivo, we generated CysLT 2 receptor-null mice by targeted gene disruption. We then examined plasma protein extravasation and neutrophil infiltration in zymosan A-induced peritoneal inflammation, plasma protein extravasation in IgE-dependent PCA, and chronic pulmonary inflammation and fibrosis induced by intratracheal injection of bleomycin. 2 Receptor Gene-disrupted Mice-Based on the nucleotide sequences of the mouse CysLT 2 receptor cDNA and genomic DNA (22, 23) , a 5-kb mouse genomic DNA fragment containing exon III to 35 base pairs (bp) of exon VI was amplified by PCR with C57BL/6 mouse genomic DNA using a sense primer of 5Ј-GACACTCAGCAACG-GAGGAATTTT-3Ј and an antisense primer of 5Ј-GACCTTGGTAGAC-ATCAGGCATAC-3Ј. The amplified fragment was subcloned into a pBluescriptII vector (Stratagene). A 1139-bp fragment containing part of exon VI and the 3Ј-flanking region was amplified by PCR with a sense primer of 5Ј-GGGGATGTGCTACATAAGGCC-3Ј and an antisense primer of 5Ј-GGTAGTATCTGTAGTCAGTTTCTG-3Ј. A neo gene from a pMC1Neo plasmid (Stratagene) and then the 1139-bp fragment were inserted tandemly into the 3Ј-side of the 5-kb fragment so that the neo gene would disrupt the region encoding the N-terminal 264 amino acids of the mouse CysLT 2 receptor. Finally, the herpes simplex virus thymidine kinase (TK) gene was inserted into the 5Ј-side of the 5-kb fragment (Fig. 1A) . The resultant targeting vector was linearized and electroporated into a C57BL/6 mouse embryonic stem cell line (Specialty Media, Phillipsburg, NJ). The embryonic stem cells were selected with G418 (200 g/ml; Invitrogen) and ganciclovir (2 M; Sigma), and homologous recombination was confirmed by Southern blot analysis of EcoRI-digested genomic DNA from each embryonic stem cell clone with a 1250-bp 3Ј-fragment as a probe located outside the targeting vector (Fig. 1A) . The embryonic stem cell clones, verified by Southern blot analysis, were microinjected into blastocysts from BALB/c mice; and chimeric males were obtained. Chimeras were bred to C57BL/6 females, and offspring were genotyped by Southern blot analysis of the tail DNA. Heterozygotes were intercrossed to obtain CysLT 2 receptor(Ϫ/Ϫ) mice. All animal studies were approved by the Animal Care and Use Committee of the Dana-Farber Cancer Institute.
EXPERIMENTAL PROCEDURES

Generation of CysLT
Northern Blot Analysis-Total RNA from the lung and spleen tissue of CysLT 2 receptor-null and wild-type mice was isolated with TriReagent (Sigma) according to the manufacturer's protocol. Poly(A) ϩ RNA was then purified with Oligotex(dT) chromatography (Qiagen). A 4-g sample of the poly(A) ϩ RNA was resolved by electrophoresis on a formaldehyde-denatured gel and transferred to a nylon membrane (Biodyne B, 0.45 m; Pall Corp., Ann Arbor, MI) with 20ϫ SSC for 24 h. The membrane was hybridized with 32 P-labeled mouse CysLT 2 receptor, CysLT 1 receptor, or glyceraldehyde-3-phosphate dehydrogenase coding region at 42°C for 18 h; washed with 2ϫ SSC, 0.1% SDS at room temperature, and then with 0.2ϫ SSC, 0.1% SDS at 60°C; and exposed at Ϫ80°C to a Kodak X-AR film with an intensifying screen for 7 days for the CysLT 2 receptor and CysLT 1 receptor, and for 1 day for glyceraldehyde-3-phosphate dehydrogenase.
Zymosan A-induced Peritoneal Inflammation-Each mouse received an intravenous injection of 0.5% Evans blue dye (10 ml of dye solution/kg of body weight) in phosphate-buffered saline (PBS) immediately before the intraperitoneal injection of 1 ml of zymosan A suspension (1 mg/ml in PBS; Sigma). Mice were killed by CO 2 30 , 60, 120, and 240 min after the injection of zymosan A, and the peritoneal cavity of each mouse was lavaged with 4 ml of cold PBS. Cells were sedimented from the lavage fluid by centrifugation at 500 ϫ g for 5 min, and Evans blue dye extravasation was assessed by light spectrophotometry of the supernatants at 610 nm. The cell pellets were suspended in 100 l of PBS, and the cells were counted. Cells (2 ϫ 10 4 ) were cytospun onto a glass slide, stained with Diff-Quik (Dade Behring, Deerfield, IL), and analyzed for cell types. The total neutrophils in the lavage fluid were calculated from the percentage of the cell type and the total cell count.
PCA-Mice received intradermal injections of 25 ng of mouse monoclonal anti-dinitrophenyl IgE (Sigma) in 25 l of saline in the right ear and 25 l of saline only in the left ear. After 20 h, mice were injected intravenously with 100 g of dinitrophenyl-human serum albumin (Sigma) and 1% Evans blue dye in 100 l of PBS. The mice were killed by CO 2 30 min after the intravenous injection, and a 6-mm diameter disk of tissue was obtained from the center of each ear. Each disk was incubated in 200 l of formamide at 55°C for 48 h. Extravasation of Evans blue dye was quantitated by spectrophotometric analysis of the formamide extracts at 610 nm, and vascular permeability enhancement was calculated as the net difference between the sensitized and control ears.
Intratracheal Injection of Bleomycin into Mice-Bleomycin sulfate (2.5 units/kg, Sigma) dissolved in saline (2.5 l/g) or saline alone was administered intratracheally to mice that had been anesthetized with an intraperitoneal injection of pentobarbital (75 mg/kg).
Histologic Assessment of Lung Tissue-Twelve days after bleomycin injection, the lower lobes of the lung were isolated, fixed for 4 h at room temperature and overnight at 4°C in 4% paraformaldehyde in 0.1 M sodium phosphate (pH 7.6), and washed twice with PBS. A portion of each lobe was embedded in paraffin in a routine manner and stained with hematoxylin and eosin. The majority of each lobe was dehydrated and embedded in accordance with the JB-4 kit from Polysciences (Warrington, PA). Sections were cut on a Reichert-Jung Supracut microtome (Leica, Deerfield, IL) with glass knives and picked up on glass slides. Some of the sections were stained using the chloroacetate esterase reaction with counterstaining by hematoxylin to depict neutrophils. To assess extracellular matrix deposition, some sections were stained with the Jones' periodic acid-methenamine silver method (37) modified with hematoxylin counterstain in the JB4-embedded lungs.
The degree of alveolar septal thickening was quantitated without knowledge of the particular strain as described previously (36) . Briefly, 5 pictures of randomly selected areas of the lower lobes of each lung at low power (ϫ10 magnifications) stained with chloroacetate esterase and hematoxylin were obtained, and the areas of septal thickening, defined as macrophage proliferation in the alveolar septa accompanied by fibroblasts, giant cells, and increased extracellular matrix, were outlined. After being converted to digital images with a flatbed computer scanner (UMAX PowerLook III) and software (Adobe Photoshop 7.0), the number of pixels contained in the areas of the digital images that had septal thickening and the number of pixels contained in the image of the entire lung field were determined with the histogram function. The total number of pixels outlined as septal thickening was divided by the total number of pixels in the entire lung field and multiplied by 100 to generate a percentage of area with septal thickening for each animal.
Bronchoalveolar Lavage Fluid Analysis in Mice with Bleomycininduced Pulmonary Fibrosis-Twelve days after treatment with bleomycin or saline, mice in each group were killed by intraperitoneal injection of an overdose of pentobarbital. Bronchoalveolar lavage (BAL) fluid was obtained by lavage with 2.25 ml of PBS with 1 mM EDTA (0.75 ml ϫ 3) through a 22-gauge intravenous canula. The fluid was centrifuged at 500 ϫ g for 5 min, and the supernatants were retained for measurement of eicosanoids. The cell pellets were resuspended in 100 l of PBS, and total and differential cell counts were obtained as described above.
Assays for eicosanoids were carried out on 2 ml of each BAL fluid supernatant to which 10,000 cpm of [ 3 H]LTC 4 (PerkinElmer Life Sciences) was added to calculate percentage recovery. Proteins were precipitated from the supernatant by the addition of a 4ϫ volume of methanol and incubation on ice for 10 min. After centrifugation at 3,000 ϫ g for 10 min, samples were dried in a vacuum centrifuge, resuspended in 50 mM sodium acetate (pH 4.0) with 10% methanol, and subjected to C 18 Sep-Pak cartridge purification (Waters Associates, Milford, MA). The eluted samples obtained from each cartridge were dried by vacuum centrifugation and resuspended in enzyme immunoassay buffer. The amounts of cys-LTs, LTB 4 , and prostaglandin E 2 were measured with enzyme immunoassay kits (Amersham Biosciences) according to the manufacturer's instructions.
Statistical Analysis-Results were expressed as mean Ϯ S.E. Student's t test was used for the statistical analysis in cases in which the variance was homogeneous, and Welch's test was used when the variance was heterogeneous. A value of p Ͻ 0.05 was considered significant. 2 Receptor Gene-disrupted Mice-A targeting vector was designed so that the neo gene insertion interrupts 85% of the coding region of the mouse CysLT 2 receptor gene (Fig. 1A) . Of 150 embryonic stem cell clones that survived in the presence of G418 and ganciclovir, two were identified as targeted clones by Southern blot analysis for the 2.6-kb band. The embryonic stem cell clones were microinjected into BALB/c mouse-derived blastocysts. Eight male chimeric mice (Ͼ50% chimerism by coat color) were obtained from each clone and bred to C57BL/6 females. The heterozygotes, verified by Southern blot analysis, were intercrossed to obtain mice homozygous for the CysLT 2 receptor-null mutation. Southern blot analysis of EcoRI-digested DNA from the progeny demonstrated a 2.6-kb band for the disrupted allele and an ϳ10-kb band for the wild-type allele, respectively, as illustrated for one litter (Fig.  1B) . Litter size from these intercrosses were normal (mean ϭ 6.6 offspring per litter; n ϭ 39 litters). Of 258 progeny genotyped from these matings, 62 were homozygotes (24.0%), 130 were heterozygotes (50.4%), and 66 were wild-type (25.6%), consistent with the expected Mendelian frequency. In addition, a similar number of male and female (29 and 33) homozygotes were produced. The CysLT 2 receptor-null mice that developed normally (mean body weight ϭ 25.7 g at 8 weeks), were fertile, and exhibited no apparent clinical abnormalities up to 10 months of age. There were no microscopic abnormalities in the CysLT 2 receptor-null mice (data not shown).
RESULTS
Generation of CysLT
Because mouse CysLT 2 receptor mRNA is most abundantly expressed in the lung, spleen, and small intestine by Northern blot analysis (22) and reverse transcription-PCR (23), we examined whether homologous recombination by the targeting vector disrupted expression of the CysLT 2 receptor mRNA in these tissues. By Northern blot analysis with poly(A) ϩ RNAs, a 5.5-kb band was dominantly detected as previously reported (22) and a 1.8-kb band that is considered to be the mature transcript based on its size (23) was also faintly detected in these tissues of the wild-type mice. In contrast, those bands were not detected in the samples from CysLT 2 receptor-null mice, although a 9-kb band was detected in the spleen of CysLT 2 receptor-null mice (Fig. 1C) . Because we used a CysLT 2 receptor coding region probe, the 9-kb band was considered to be an unstable transcript that contained part of exon VI. Expression of an aberrant and unstable transcript was also the case for the LTC 4 synthase-null mice (34). Importantly, there was no change in the CysLT 1 receptor mRNA expression in these tissues by the disruption of the CysLT 2 receptor gene (Fig. 1C) .
Role of the CysLT 2 Receptor in Zymosan A-induced Peritoneal
Inflammation-Although we previously demonstrated that the early plasma protein extravasation in zymosan A-induced peritoneal inflammation is reduced by ϳ50% in LTC 4 synthase-null mice (34) and is similarly reduced in CysLT 1 receptor-null mice (35), we performed the same study to determine whether there exists any role for the CysLT 2 receptor. Plasma protein extravasation assessed 30 to 240 min after zymosan A injection in CysLT 2 receptor-null mice was similar at all time points compared with that of the wild-type mice ( Fig. 2A) .
We also examined neutrophil infiltration, which generally peaks 240 min after the injection of zymosan A (32, 38, 39). As assessed with neutrophil counts 240 min after the injection, there was no significant difference in neutrophil infiltration between CysLT 2 receptor-null and wild-type mice (Fig. 2B) .
Role of the CysLT 2 Receptor in Mast Cell-dependent PCA-We previously demonstrated that the local edema induced by IgE-dependent PCA is reduced by 50% in the LTC 4 synthase-null mice as compared with their wild-type littermates (34) and that this cys-LT-mediated response is dominantly through the CysLT 1 receptor (35) . Nonetheless, to determine whether the CysLT 2 receptor is involved, we examined plasma protein extravasation induced by IgE-dependent PCA in CysLT 2 receptor-null mice. Unexpectedly, Evans blue dye extravasation in the ear of CysLT 2 receptor-null mice was reduced in a preliminary experiment. Thus, we included the CysLT 1 receptor-null mice in three more studies. Plasma protein extravasation was reduced by ϳ65% 30 min after antigen challenge as compared with the level in the wild-type litter- mates, and the reduction was similar to that of CysLT 1 receptor-null mice (Fig. 3) .
Role of the CysLT 2 Receptor in Bleomycin-induced Pulmonary Fibrosis-We previously demonstrated that bleomycininduced pulmonary chronic inflammation and fibrosis are attenuated in LTC 4 synthase-null mice but exacerbated in CysLT 1 receptor-null mice (36) . To define a role for the CysLT 2 receptor in the pathobiology of chronic inflammation with fibrosis, we injected bleomycin into the tracheas of CysLT 2 receptor-null mice and their wild-type littermates and examined lung histology and cys-LT levels in the BAL fluid 12 days after the injection. The lung tissue of bleomycin-treated CysLT 2 receptor-null mice had less septal thickening, with less accumulation of monocyte/macrophages, giant cells, fibroblasts, and eosinophils and less extracellular matrix deposition than that of their bleomycin-treated wild-type littermates (Fig. 4,  a-f) . We used the Jones' periodic acid-methenamine silver method with modifications to assess the deposition of extracellular matrix proteins beneath the pleura, around the bronchi, and in the alveolar septa. After bleomycin treatment, the amount of black fibrillar material was less in the lung tissue of the CysLT 2 receptor-null mice as compared with lung tissue from the wild-type mice (Fig. 4, g-l) .
To quantitate the degree of bleomycin-induced inflammation and fibrosis, we analyzed the sections stained with chloroacetate esterase and hematoxylin by comparing digital images of the areas of alveolar septal thickening and the total area of the lower lung lobes of the mice 12 days after bleomycin injection. After 20 h, mice were injected intravenously with 100 g of dinitrophenyl-human serum albumin and 1% Evans blue dye in 100 l of PBS. A 6-mm diameter ear disk was isolated 30 min after challenge, and Evans blue dye was extracted in 200 l of formamide at 55°C for 48 h. Extravasation of Evans blue dye was quantitated by spectrophotometric analysis at 610 nm. The difference between the absorbance of the right and left ear extracts representing the net extravasation in the sensitized ear was expressed as the mean Ϯ S.E. Results are combined from three independent analyses (n ϭ 10 mice per group). *, p Ͻ 0.001.
FIG. 4.
Histologic assessment of bleomycin-induced pulmonary fibrosis in CysLT 2 receptor-null mice. The lower lobes of the lungs were examined histologically 12 days after animals received an intratracheal injection of saline or bleomycin. Sections of lung from saline-treated wild-type mice (a, low power: ϫ10 objective; d, high power: ϫ50 objective) and bleomycin-treated wild-type (b, low power; e, high power) and CysLT 2 receptor-null (c, low power; f, high power) mice were stained with hematoxylin and eosin (a-c), or by the chloroacetate esterase reaction with counterstaining with hematoxylin (d-f). Sections of lung from saline-treated wild-type mice (g, low power; j, high power) and bleomycin-treated wild-type (h, low power; k, high power) and CysLT 2 receptor-null (i, low power; l, high power) mice were stained with the Jones' periodic acid-methenamine silver method with hematoxylin counterstain. Reticular fibers (type III collagen) and basement membranes were stained dark brown to black.
The area of the lower lobes with alveolar septal thickening in CysLT 2 receptor-null mice was significantly reduced to only 39% that of wild-type mice (Table I) . Bleomycin treatment significantly increased the amounts of cys-LTs in the BAL fluid in both wild-type mice and CysLT 2 receptor-null mice. Despite the attenuation of septal thickening, bleomycin-treated CysLT 2 receptor-null mice had levels of cys-LTs comparable with those of the bleomycin-treated wild-type mice (Table I) . Bleomycin treatment did not increase the amounts of LTB 4 in either wild-type mice or CysLT 2 receptor-null mice. Although bleomycin treatment did increase the amount of prostaglandin E 2 in wild-type mice, but not in CysLT 2 receptor-null mice (Table I) , the amounts of prostaglandin E 2 recovered from both strains with bleomycin injury were not different. DISCUSSION We generated CysLT 2 receptor-null mice by targeted gene disruption to seek in vivo evidence for the role of this receptor in cys-LT-mediated pathobiology. Despite the extensive characterization of the CysLT 2 receptor with transfected cells (7-9, 22, 23) and human umbilical vein endothelial cells (17, 18, 40) , little is known about the role of the second receptor in in vivo inflammatory responses, because of the lack of specific antagonists for it. We have found that the CysLT 2 receptor mediates increased vascular permeability in IgE-dependent PCA and macrophage and fibroblast accumulation and extracellular matrix protein deposition in response to bleomycin. LTC 4 and LTD 4 directly elicit transient vasoconstriction of small arterioles and then increased vascular permeability in postcapillary venules (41, 42) , where contraction of endothelial cells is considered to be required for the plasma protein leakage (43) . Because increased vascular permeability induced by either intraperitoneal injection of zymosan A or IgE-dependent PCA is attenuated in the CysLT 1 receptor-null mice (35) to the same extent as in the LTC 4 synthase-null mice (34), we anticipated that the effect of CysLT 2 receptor deficiency on increased vascular permeability in these acute inflammatory responses would be negligible. Surprisingly, increased vascular permeability by IgE-dependent PCA, but not in zymosan-induced peritoneal inflammation, was attenuated in the CysLT 2 receptor-null mice. Furthermore, this protection was equal to that observed in the CysLT 1 receptor-null mice in the same set of experiments (Fig. 3) . The lack of attenuation of the vascular leak in the peritoneal cavity in the CysLT 2 receptor-null mice would imply heterogeneity of receptor distribution in the microvasculature across tissues (Fig. 2) .
There was no impairment of mast cell degranulation by morphologic analysis (data not shown), indicating that the attenuation involved the microvasculature. The CysLT 2 receptor mRNA is detected in endothelial cells of the mouse heart by in situ hybridization (23) and on human umbilical vein endothelial cells in a 1000-fold excess to the CysLT 1 receptor by quantitative reverse transcription-PCR (17, 18) . Moreover, the calcium response of the human umbilical vein endothelial cells to the cys-LTs was attributed to the CysLT 2 receptor because there was no inhibition by a selective CysLT 1 receptor antagonist and some inhibition by a partial CysLT 2 receptor agonist. That the magnitude of the attenuation of the PCA was approximately equal in each of three independent experiments for the CysLT 2 receptor-null and CysLT 1 receptor-null mice and for the overall mean implies that the inhibition is linked, possibly through CysLT 2 and CysLT 1 receptor heterodimers. Heterodimer formation has been reported for other G protein-coupled receptors, such as opioid (44) and chemokine (45) receptors.
In this study, we have shown that CysLT 2 is the receptor responsible for mediating the contribution of the cys-LTs to bleomycin-induced chronic pulmonary inflammation and fibrosis. The levels of cys-LTs in the BAL fluid of bleomycin-treated CysLT 2 receptor-null mice and wild-type mice remained comparable (Table I) . Thus, either the lack of cys-LT production as in the LTC 4 synthase-null mice (36) or the lack of the CysLT 2 receptor significantly attenuates the chronic injury (Fig. 4) . In contrast, the CysLT 1 receptor-null mice were found to have increased bleomycin-induced pulmonary inflammation and increased levels of cys-LTs in BAL fluid relative to their controls (36) . The source of cys-LTs in this response is most likely alveolar and interstitial macrophages as cells of this lineage in several species generate cys-LTs in response to a range of ligands (46 -49) .
Mouse skin fibroblasts express both CysLT 1 and CysLT 2 receptors by in situ hybridization (22) . Before the CysLT 1 and CysLT 2 receptors were defined by their cloning, it was shown that LTC 4 and LTD 4 could stimulate [ 3 H]thymidine incorporation by in vitro cultured human skin fibroblasts in the presence of indomethacin and that the effect of LTC 4 was slightly superior to that of LTD 4 (50) . In addition, LTC 4 and, to a lesser extent, LTD 4 could stimulate collagen synthesis of rat lung fibroblasts in vitro and LTC 4 could directly bind to the cells (51) . These earlier studies revealing a functional receptor for cys-LTs on fibroblasts analyzed in vitro are compatible with a CysLT 2 receptor-mediated response based on the efficacy of LTC 4 . Our findings that CysLT 2 receptor-null mice have a significant reduction in bleomycin-induced pulmonary fibrosis could reflect a dominant role for this receptor in the fibroblast component of the response.
We generated CysLT 2 receptor-null mice and then demonstrated a role for the CysLT 2 receptor in inflammatory responses in vivo. Our studies highlight the CysLT 2 receptor as a potential therapeutic target for the treatment of idiopathic pulmonary fibrosis, for which no efficient interventions are available (52) .
